Carregant...
Fitxers
Tipus de document
ArticleVersió
Versió acceptadaData de publicació
Tots els drets reservats
Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document: https://hdl.handle.net/2445/167358
Inhibition of human enhancer of zeste homolog 2 with tambjamine analogs
Títol de la revista
Director/Tutor
ISSN de la revista
Títol del volum
Recurs relacionat
Resum
Combining computational modeling, de novo compound synthesis, and in vitro and cellular assays, we have performed an inhibition study against the enhancer of zeste homolog 2 (EZH2) histone-lysine N-methyltransferase. This enzyme is an important catalytic component of the PRC2 complex whose alterations have been associated with different cancers. We introduce here several tambjamine-inspired derivatives with low micromolar in vitro activity that produce a significant decrease in histone 3 trimethylation levels in cancer cells. We demonstrate binding at the methyl transfer active site, showing, in addition, that the EZH2 isolated crystal structure is capable of being used in molecular screening studies. Altogether, this work provides a successful molecular model that will help in the identification of new specific EZH2 inhibitors and identify a novel class of tambjamine-derived EZH2 inhibitors with promising activities for their use in cancer treatment.
Matèries (anglès)
Citació
Citació
KOTEV, Martin, MANUEL-MANRESA, Pilar, HERNANDO, Elsa, SOTO CERRATO, Vanessa, OROZCO LÓPEZ, Modesto, QUESADA, Roberto, PÉREZ TOMÁS, Ricardo e., GUALLAR, Victor. Inhibition of human enhancer of zeste homolog 2 with tambjamine analogs. _Journal of Chemical Information and Modeling_. 2018. Vol. 57, núm. 8, pàgs. 2089-2098. [consulta: 27 de gener de 2026]. ISSN: 1549-9596. [Disponible a: https://hdl.handle.net/2445/167358]